{"url":"https://lda.senate.gov/api/v1/filings/659e1cbe-4de9-4055-9bc9-e262607de686/","filing_uuid":"659e1cbe-4de9-4055-9bc9-e262607de686","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/659e1cbe-4de9-4055-9bc9-e262607de686/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Pamela Bradley","dt_posted":"2021-01-19T20:48:44-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1551 Eastlake Ave E","registrant_address_2":"Ste 200","registrant_different_address":null,"registrant_city":"Seattle","registrant_state":"WA","registrant_zip":"98102","registrant":{"id":401105856,"url":"https://lda.senate.gov/api/v1/registrants/401105856/","house_registrant_id":44954,"name":"ADAPTIVE BIOTECHNOLOGIES","description":"biotech","address_1":"1551 Eastlake Ave E","address_2":"Ste 200","address_3":null,"address_4":null,"city":"Seattle","state":"WA","state_display":"Washington","zip":"98102","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARY LANCELOTTA","contact_telephone":"+1 205-908-5603","dt_updated":"2023-02-28T15:18:22.324268-05:00"},"client":{"id":208107,"url":"https://lda.senate.gov/api/v1/clients/208107/","client_id":12,"name":"ADAPTIVE BIOTECHNOLOGIES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"WA","state_display":"Washington","country":"US","country_display":"United States of America","ppb_state":"WA","ppb_state_display":"Washington","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":92849,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":"LYNN","last_name":"BRADLEY","suffix":null,"suffix_display":null},"covered_position":"Covered legislative branch official","new":true}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":92849,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":"LYNN","last_name":"BRADLEY","suffix":null,"suffix_display":null},"covered_position":"Covered legislative branch official","new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"H.R.6102 and S.3404, Verifying Accurate Leading-edge IVCT Development Act of 2020, all provisions","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":92849,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":"LYNN","last_name":"BRADLEY","suffix":null,"suffix_display":null},"covered_position":"Covered legislative branch official","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}